As you know, hepatocellular carcinoma is a challenge. Too often patients are diagnosed at an advanced stage; often patients are not referred based on a nihilistic attitude which should belong to the past. Several therapeutic options are available and to select the best for each patient requires expertise.
For the benefit of our patients we plan to organize a HCC Online Update starting at 14:00 on the 31th March 2022 focusing on hepatocellular carcinoma and bringing together the different specialties.
This event will have CME recognition.
Prof. Dufour, Lausanne
Opening
I. Labgaa, Lausanne
Time to get more information from the blood
T. Koessler, Genève
What after immunotherapy
Prof. J. Calderaro, Paris
How histology impacts on HCC management
Break
Recipient Price
M. Pinter, Vienna
Predictors of response to therapy
Prof. G. Abou-Alfa, New York
What is coming as new therapies
Prof. Dufour, Lausanne
Closing remarks
Networking
